Does Treatment with Corticosteroids and Cyclosporine Reduce Transglutaminase Type 2 Expression in the Renal Tissue of Patients with Membranous Nephropathy?

Publisher： Karger

E-ISSN： 1660-2110|121|1-2|c60-c67

ISSN： 1660-2110

Source： Nephron Clin Pract, Vol.121, Iss.1-2, 2012-10, pp. : c60-c67

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Antibodies to m‐type phospholipase A2 receptor in children with idiopathic membranous nephropathy

By  

NEPHROLOGY, Vol. 20, Iss. 8, 2015-08 ,pp. : 572-575

John Wiley & Sons Inc

Access to resources Recommend Favorite

Elevated ε-(γ-Glutamyl)lysine in Human Diabetic Nephropathy Results from Increased Expression and Cellular Release of Tissue Transglutaminase

By  

Nephron Clin Pract, Vol. 97, Iss. 3, 2004-11 ,pp. : c108-c117

Karger

Access to resources Recommend Favorite

Proteinuria in Type 2 Diabetic Patients with Renal Impairment: The Changing Face of Diabetic Nephropathy

By  

Nephron Clin Pract, Vol. 118, Iss. 4, 2011-02 ,pp. : c331-c338

Karger

Access to resources Recommend Favorite

Prevalence and Severity of Anaemia in Patients with Type 2 Diabetic Nephropathy and Different Degrees of Chronic Renal Insufficiency

By  

Nephron Clin Pract, Vol. 105, Iss. 2, 2006-11 ,pp. : c62-c67

Karger

Access to resources Recommend Favorite

CD68 and MCP-1/CCR2 Expression of Initial Biopsies Reflect the Outcomes of Membranous Nephropathy

By  

Nephron Clin Pract, Vol. 98, Iss. 1, 2004-11 ,pp. : c25-c34

Karger

Access to resources Recommend Favorite